Clinical Case Reports (Nov 2022)

Lipohypertrophy contributing to severe diabetic ketoacidosis in type 1 diabetes: An increasing problem in the context of the COVID‐19 pandemic?

  • Emilia Imogen Smith,
  • Andra Ciutac,
  • Jamie C. Smith

DOI
https://doi.org/10.1002/ccr3.6517
Journal volume & issue
Vol. 10, no. 11
pp. n/a – n/a

Abstract

Read online

Abstract A 57‐year‐old man with type 1 diabetes was admitted with diabetic ketoacidosis during the COVID‐19 pandemic. On examination, there was evidence of severe lipohypertrophy on his abdomen. Repeated injection of subcutaneous insulin into areas of lipohypertrophy was thought to have contributed to the development of ketoacidosis.

Keywords